The International Commission on Radiation Units and Measurements (ICRU), since its
inception in 1925, has had as its principal objective the development of internationally …

The potential of α-particle emitters to treat cancer has been recognized since the early
1900s. Advances in the targeted delivery of radionuclides and radionuclide conjugation …

The availability of quantitative three-dimensional in vivo data on radionuclide distributions
within the body makes it possible to calculate the corresponding nonuniform distribution of …

The three main weapons in the arsenal for cancer treatment continue to be surgery, external
beam radiotherapy, and chemotherapy. Nevertheless, inoperable tumors, tumors situated …

Internal dosimetry deals with the determination of the amount and the spatial and temporal
distribution of radiation energy deposited in tissue by radionuclideswithin the body. Nuclear …

Radiopharmaceutical therapy, traditionally limited to refractory metastatic cancer, is being
increasingly used at earlier stages, such as for treating minimal residual disease. The aim of …

Patients undergoing nuclear medicine procedures for cancer therapy are administered
radiopharmaceuticals that emit various types of radiation. Because radiation has differential …

Radiopharmaceutical therapy is growing rapidly. However, yet to be addressed is the
implementation of methods to plan treatments for circulating tumor cells, disseminated tumor …

Background Targeted radionuclide therapy (TRT) is gaining importance. For TRT to be also
used as adjuvant therapy or for treating minimal residual disease, there is a need to …

Abstract Pouget, JP., Santoro, L., Raymond, L., Chouin, N., Bardiès, M., Bascoul-Mollevi, C.,
Huguet, H., Azria, D., Kotzki, PO., Pè legrin, M., Vivès, E. and Pèlegrin, A. Cell Membrane is …